| Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the … R Fleischmann, J Vencovsky, RF van Vollenhoven, D Borenstein, J Box, ... Annals of the rheumatic diseases 68 (6), 805-811, 2009 | 436 | 2009 |
| Systemic lupus erythematosus in three ethnic groups. VIII. Predictors of early mortality in the LUMINA cohort GS Alarcón, G McGwin, Jr, HM Bastian, J Roseman, J Lisse, BJ Fessler, ... Arthritis Care & Research: Official Journal of the American College of …, 2001 | 400 | 2001 |
| International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials AM Orbai, M De Wit, P Mease, JA Shea, L Gossec, YY Leung, W Tillett, ... Annals of the rheumatic diseases 76 (4), 673-680, 2017 | 284 | 2017 |
| Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course GS Alarcón, J Roseman, AA Bartolucci, AW Friedman, JM Moulds, N Goel, ... Arthritis & Rheumatism 41 (7), 1173-1180, 1998 | 260 | 1998 |
| Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors TA Mcnearney, JD Reveille, M Fischbach, AW Friedman, JR Lisse, N Goel, ... Arthritis Care & Research 57 (2), 318-326, 2007 | 248 | 2007 |
| Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ... The Lancet Oncology 22 (11), 1507-1517, 2021 | 232 | 2021 |
| Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021 LC Coates, ER Soriano, N Corp, H Bertheussen, K Callis Duffin, ... Nature Reviews Rheumatology 18 (8), 465-479, 2022 | 210 | 2022 |
| Certolizumab pegol N Goel, S Stephens MAbs 2 (2), 137-147, 2010 | 167 | 2010 |
| Efficacy and safety of certolizumab pegol in a broad population of patients with active rheumatoid arthritis: results from the REALISTIC phase IIIb study ME Weinblatt, R Fleischmann, TWJ Huizinga, P Emery, J Pope, ... Rheumatology 51 (12), 2204-2214, 2012 | 151 | 2012 |
| Mechanical sensation and pain thresholds in patients with chronic arthropathies JA Hendiani, KN Westlund, N Lawand, N Goel, J Lisse, T McNearney The journal of pain 4 (4), 203-211, 2003 | 142 | 2003 |
| Updating the psoriatic arthritis (PsA) core domain set: a report from the PsA workshop at OMERACT 2016 AM Orbai, M De Wit, PJ Mease, KC Duffin, M Elmamoun, W Tillett, ... The Journal of rheumatology 44 (10), 1522-1528, 2017 | 118 | 2017 |
| The patient perspective on absence of disease activity in rheumatoid arthritis: a survey to identify key domains of patient-perceived remission LHD Van Tuyl, M Sadlonova, S Hewlett, B Davis, C Flurey, N Goel, ... Annals of the rheumatic diseases 76 (5), 855-861, 2017 | 101 | 2017 |
| Certolizumab pegol plus MTX administered every 4 weeks is effective in patients with RA who are partial responders to MTX E Choy, F McKenna, J Vencovsky, R Valente, N Goel, B VanLunen, ... Rheumatology 51 (7), 1226-1234, 2012 | 98 | 2012 |
| Familial antiphospholipid antibody syndrome: criteria for disease and evidence for autosomal dominant inheritance N Goel, TL Ortel, D Bali, JP Anderson, IS Gourley, H Smith, CA Morris, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1999 | 96 | 1999 |
| Systemic lupus erythematosus in three ethnic groups: IV. Factors associated with self‐reported functional outcome in a large cohort study AW Friedman, GS Alarcón, G McGwin Jr, KV Straaton, J Roseman, N Goel, ... Arthritis Care & Research 12 (4), 256-266, 1999 | 84 | 1999 |
| Lack of correlation between serum soluble Fas/APO‐1 levels and autoimmune disease N Goel, EST William Clair, JA Fleming, DT Ulrich, DH Lynch, MF Seldin Arthritis & Rheumatism 38 (12), 1738-1743, 1995 | 82 | 1995 |
| Genetic analysis of multiplex rheumatoid arthritis families D Bali, S Gourley, DD Kostyu, N Goel, I Bruce, A Bell, DJ Walker, K Tran, ... Genes & Immunity 1 (1), 28-36, 1999 | 76 | 1999 |
| Developing a construct to evaluate flares in rheumatoid arthritis: a conceptual report of the OMERACT RA Flare Definition Working Group R Alten, C Pohl, EH Choy, R Christensen, DE Furst, SE Hewlett, A Leong, ... The Journal of Rheumatology 38 (8), 1745-1750, 2011 | 72 | 2011 |
| A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: a GRAPPA-OMERACT initiative P Højgaard, L Klokker, AM Orbai, K Holmsted, EM Bartels, YY Leung, ... Seminars in arthritis and rheumatism 47 (5), 654-665, 2018 | 67 | 2018 |
| Fracture Reduction Affects Medicare Economics (FRAME): impact of increased osteoporosis diagnosis and treatment AB King, KG Saag, RT Burge, M Pisu, N Goel Osteoporosis international 16, 1545-1557, 2005 | 59 | 2005 |
